Perrigo Company PLC (NYSE:PRGO)
| 59.02 Delayed Data As of Jan 17 |  -0.49 / -0.82%Today’s Change | 40.68 Today|||52-Week Range 60.24 | +14.25% Year-to-Date |
Latest PRGO News | Press Releases
| Why Perrigo Shares Are Jumping Today Jan 14 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 59.51 |
| Today’s open | 59.86 |
| Day’s range | 58.79 - 60.24 |
| Volume | 1,079,979 |
| Average volume (3 months) | 1,086,529 |
| Market cap | $8.0B |
Data as of 6:30pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +13.17% |
| Earnings growth (this year) | -12.40% |
| Earnings growth (next 5 years) | +3.85% |
| Revenue growth (last year) | -4.31% |
| P/E ratio | 32.8 |
| Price/Sales | 1.13 |
| Price/Book | 1.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IONSIonis Pharmaceutical... | -1.33 | -2.16% |
| JAZZJazz Pharmaceuticals... | -0.54 | -0.36% |
| HZNPHorizon Therapeutics... | +0.11 | +0.29% |
| CTLTCatalent Inc | -0.59 | -0.96% |
Data as of 6:30pm ET, 01/17/2020
Financials
| Next reporting date | March 6, 2020 |
| EPS forecast (this quarter) | $1.02 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $131.0M |
| Net profit margin | 2.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
